Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2010

View Archived Issues

Alnylam provides key goals for next 18 months

Pharmasset provides new data on HCV candidate PSI-7851

ERalphaS118-P a potential biomarker for breast cancer response to tamoxifen

Novo Nordisk commences phase I trial with long-acting oral GLP-1 analogue

Sciele Pharma changes company name to Shionogi Pharma

Isis adds new drug to treat hypertriglyceridemia to development pipeline

Amicus Therapeutics presents development progress with Amigal

InterMune provides update on 2010 development program for RG-7227

Sorrento enters antibody alliance for MRSA infections

Idenix reports updated information on three of its HCV programs

AnaptysBio and Roche sign agreement for development of novel antibody therapeutics

Pharmaxis acquires Topigen

Shionogi receives marketing approval for peramivir in Japan

Genaera to sell remaining proprietary assets

Spectrum completes enrollment in second phase III pivotal apaziquone trial

Eisai submits application for approval of additional indication of Tambocor in Japan

Genfit reports results from phase I safety study of GFT-505/simvastatin combination

siRNA-nanosome formulations inhibit HCV RNA replication in interferon-resistant replicon cells

Activated protein C analogues slow progression in ALS model

Top2alpha proteasomal degradation can be inhibited to enhance cancer treatment

Novel sulfonylureas in development for diabetes therapy at Concert Pharmaceuticals

Bristol-Myers Squibb presents novel hepatitis C virus inhibitors

Yakult Honsha discovers novel Plk-1 inhibitors as oncolytics

Novel peptides for the diagnosis of invasive brain cancer described by U.S. scientists

Actelion Pharmaceuticals discloses novel antibacterials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...